Research validated by Valeo Health Experts
Our research is backed by clinical validation and solid evidence. Dive into our studies to discover the outcomes and the scientific principles that underpin our care model.
Research validated by Valeo Health Experts
Our research is backed by clinical validation and solid evidence. Dive into our studies to discover the outcomes and the scientific principles that underpin our care model.
Key Results
Down from 19.1% in 2022 across 28,904 UAE clients tested 2021–2026
Down from 7.20 mg/L in 2022, falling consistently year over year with no reversals
Latest releases
The Quiet Crisis: What five years of biomarkers data reveals about men's health in the UAE
Men in the UAE carry a disproportionate cardiometabolic and hormonal health burden, yet engage with preventive health at lower rates and later ages than women. Population-level biomarker data characterising this burden across age and time is largely absent from the GCC literature. This report presents findings from five years of male client biomarker data at Valeo Health, Dubai, with a particular focus on hormonal trends, cardiometabolic risk, and the emerging signal of rising male estradiol — a
Key findings :The Longevity Gap: Who Ages Well in the UAE — and Who Doesn't A Biomarker-Based Longevity Analysis
Biological ageing — the rate at which the body accumulates functional decline independent of chronological age— is increasingly measurable through composite biomarker-based longevity scores. Dubai and the UAE have emerged as global hubs for longevity science and preventive health investment, yet no large-scale, real-world longitudinal longevity score dataset from this region has been published. How nationality, gender, and age interact to shape biological aging trajectories in the UAE's uniquely
Key findings :The Quiet Crisis: What five years of biomarkers data reveals about men's health in the UAE
Men in the UAE carry a disproportionate cardiometabolic and hormonal health burden, yet engage with preventive health at lower rates and later ages than women. Population-level biomarker data characterising this burden across age and time is largely absent from the GCC literature. This report presents findings from five years of male client biomarker data at Valeo Health, Dubai, with a particular focus on hormonal trends, cardiometabolic risk, and the emerging signal of rising male estradiol — a
Key findings :The Longevity Gap: Who Ages Well in the UAE — and Who Doesn't A Biomarker-Based Longevity Analysis
Biological ageing — the rate at which the body accumulates functional decline independent of chronological age— is increasingly measurable through composite biomarker-based longevity scores. Dubai and the UAE have emerged as global hubs for longevity science and preventive health investment, yet no large-scale, real-world longitudinal longevity score dataset from this region has been published. How nationality, gender, and age interact to shape biological aging trajectories in the UAE's uniquely
Key findings :The Longevity Gap: Who Ages Well in the UAE — and Who Doesn't A Biomarker-Based Longevity Analysis
Biological ageing — the rate at which the body accumulates functional decline independent of chronological age— is increasingly measurable through composite biomarker-based longevity scores. Dubai and the UAE have emerged as global hubs for longevity science and preventive health investment, yet no large-scale, real-world longitudinal longevity score dataset from this region has been published. How nationality, gender, and age interact to shape biological aging trajectories in the UAE's uniquely
Key findings :The Quiet Crisis: What five years of biomarkers data reveals about men's health in the UAE
Men in the UAE carry a disproportionate cardiometabolic and hormonal health burden, yet engage with preventive health at lower rates and later ages than women. Population-level biomarker data characterising this burden across age and time is largely absent from the GCC literature. This report presents findings from five years of male client biomarker data at Valeo Health, Dubai, with a particular focus on hormonal trends, cardiometabolic risk, and the emerging signal of rising male estradiol — a
Key findings :